Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema ; volume:21 ; number:1 ; day:15 ; month:1 ; year:2021 ; pages:1-10 ; date:12.2021
BMC ophthalmology ; 21, Heft 1 (15.1.2021), 1-10, 12.2021
- Urheber
-
Yoon, Chang Ki
Sagong, Min
Shin, Jae Pil
Lee, Sang Joon
Lee, Joo Eun
Lee, Ji Eun
Chung, Inyoung
Jeong, Woo Jin
Pak, Kang Yeun
Kim, Hyun Woong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12886-020-01786-2
- URN
-
urn:nbn:de:101:1-2021030613042822110065
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yoon, Chang Ki
- Sagong, Min
- Shin, Jae Pil
- Lee, Sang Joon
- Lee, Joo Eun
- Lee, Ji Eun
- Chung, Inyoung
- Jeong, Woo Jin
- Pak, Kang Yeun
- Kim, Hyun Woong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes
Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
Pseudophakic macular edema in nondiabetic and diabetic patients without diabetic retinopathy treated with intravitreal dexamethasone implant
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
Mid-term safety and effectiveness of macular peeling one month after intravitreal dexamethasone implant for tractional diabetic macular edema
Real-world experience on intravitreal dexamethasone implant in patients with macular edema scheduled to undergo cataract surgery
Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study
The effect of glycosylated hemoglobin levels on the response to intravitreal dexamethasone implant for treating diabetic macular edema
A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes
Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
Pseudophakic macular edema in nondiabetic and diabetic patients without diabetic retinopathy treated with intravitreal dexamethasone implant
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
Mid-term safety and effectiveness of macular peeling one month after intravitreal dexamethasone implant for tractional diabetic macular edema
Real-world experience on intravitreal dexamethasone implant in patients with macular edema scheduled to undergo cataract surgery
Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study
The effect of glycosylated hemoglobin levels on the response to intravitreal dexamethasone implant for treating diabetic macular edema
A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes
Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
Pseudophakic macular edema in nondiabetic and diabetic patients without diabetic retinopathy treated with intravitreal dexamethasone implant
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
Mid-term safety and effectiveness of macular peeling one month after intravitreal dexamethasone implant for tractional diabetic macular edema
Real-world experience on intravitreal dexamethasone implant in patients with macular edema scheduled to undergo cataract surgery
Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study
The effect of glycosylated hemoglobin levels on the response to intravitreal dexamethasone implant for treating diabetic macular edema